Works matching IS 15228517 AND DT 2015 AND VI 17 AND IP 11

Results: 16

Evidence for rCBV as an early response marker following bevacizumab treatment.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1539, doi. 10.1093/neuonc/nov199

By:

Pope, Whitney B.

Publication type:

Article

Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1525, doi. 10.1093/neuonc/nov117

By:

Wangaryattawanich, Pattana;
Hatami, Masumeh;
Jixin Wang;
Thomas, Ginu;
Flanders, Adam;
Kirby, Justin;
Wintermark, Max;
Huang, Erich S.;
Bakhtiari, Ali Shojaee;
Luedi, Markus M.;
Hashmi, Syed S.;
Rubin, Daniel L.;
Chen, James Y.;
Hwang, Scott N.;
Freymann, John;
Holder, Chad A.;
Zinn, Pascal O.;
Colen, Rivka R.

Publication type:

Article

Telomere maintenance and the etiology of adult glioma.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1445, doi. 10.1093/neuonc/nov082

By:

Walsh, Kyle M.;
Wiencke, John K.;
Lachance, Daniel H.;
Wiemels, Joseph L.;
Molinaro, Annette M.;
Eckel-Passow, Jeanette E.;
Jenkins, Robert B.;
Wrensch, Margaret R.

Publication type:

Article

Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1425, doi. 10.1093/neuonc/nov198

By:

Hegi, Monika E.;
Stupp, Roger

Publication type:

Article

The CD40/CD40L axis in glioma progression and therapy.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1428, doi. 10.1093/neuonc/nov138

By:

Walker, Paul R.;
Migliorini, Denis

Publication type:

Article

Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1463, doi. 10.1093/neuonc/nov041

By:

Singh, Melissa M.;
Johnson, Blake;
Venkatarayan, Avinashnarayan;
Flores, Elsa R.;
Jianping Zhang;
Xiaoping Su;
Barton, Michelle;
Lang, Frederick;
Chandra, Joya

Publication type:

Article

Society news.

Published in:: Neuro-Oncology, 2015, v. 17, n. 11, p. 1541, doi. 10.1093/neuonc/nov251
Publication type:: Article

pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1514, doi. 10.1093/neuonc/nov106

By:

Harris, Robert J.;
Cloughesy, Timothy F.;
Liau, Linda M.;
Prins, Robert M.;
Antonios, Joseph P.;
Debiao Li;
Yong, William H.;
Pope, Whitney B.;
Lai, Albert;
Nghiemphu, Phioanh L.;
Ellingson, Benjamin M.

Publication type:

Article

From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1434, doi. 10.1093/neuonc/nov118

By:

Galldiks, Norbert;
Langen, Karl-Josef;
Pope, Whitney B.

Publication type:

Article

CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1497, doi. 10.1093/neuonc/nov092

By:

Viaccoz, Aurélien;
Ducray, François;
Tholance, Yannick;
Barcelos, Gleicy Keli;
Thomas-Maisonneuve, Laure;
Ghesquières, Hervé;
Meyronet, David;
Quadrio, Isabelle;
Cartalat-Carel, Stéphanie;
Louis-Tisserand, Guy;
Jouanneau, Emmanuel;
Guyotat, Jacques;
Honnorat, Jérôme;
Perret-Liaudet, Armand

Publication type:

Article

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1504, doi. 10.1093/neuonc/nov104

By:

Field, Kathryn M.;
Simes, John;
Nowak, Anna K.;
Cher, Lawrence;
Wheeler, Helen;
Hovey, Elizabeth J.;
Brown, Christopher S. B.;
Barnes, Elizabeth H.;
Sawkins, Kate;
Livingstone, Ann;
Freilich, Ron;
Phal, Pramit M.;
Fitt, Greg;
Rosenthal, Mark A.

Publication type:

Article

CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1453, doi. 10.1093/neuonc/nov090

By:

Masashi Chonan;
Ryuta Saito;
Takuhiro Shoji;
Ichiyo Shibahara;
Masayuki Kanamori;
Yukihiko Sonoda;
Mika Watanabe;
Toshiaki Kikuchi;
Naoto Ishii;
Teiji Tominaga

Publication type:

Article

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1538, doi. 10.1093/neuonc/nov163

By:

Boxerman, Jerrold L.;
Schmainda, Kathleen M.;
Zheng Zhang;
Barboriak, Daniel P.;
Pope, Whitney B.

Publication type:

Article

Highlights from the Literature.

Published in:: Neuro-Oncology, 2015, v. 17, n. 11, p. 1431, doi. 10.1093/neuonc/nov252
Publication type:: Article

Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1486, doi. 10.1093/neuonc/nov045

By:

Bergthold, Guillaume;
Bandopadhayay, Pratiti;
Hoshida, Yujin;
Ramkissoon, Shakti;
Ramkissoon, Lori;
Rich, Benjamin;
Maire, Cecile L.;
Paolella, Brenton R.;
Schumacher, Steven E.;
Tabak, Barbara;
Ferrer-Luna, Ruben;
Ozek, Memet;
Sav, Aydin;
Santagata, Sandro;
Patrick Yung Wen;
Goumnerova, Liliana C.;
Ligon, Azra H.;
Stiles, Charles;
Segal, Rosalind;
Golub, Todd

Publication type:

Article

The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.

Published in:

Neuro-Oncology, 2015, v. 17, n. 11, p. 1474, doi. 10.1093/neuonc/nov042

By:

Fangyong Dong;
Eibach, Michael;
Bartsch, Jörg W.;
Dolga, Amalia M.;
Schlomann, Uwe;
Conrad, Catharina;
Schieber, Susanne;
Schilling, Oliver;
Biniossek, Martin L.;
Culmsee, Carsten;
Strik, Herwig;
Koller, Garrit;
Carl, Barbara;
Nimsky, Christopher

Publication type:

Article